With $42 billion in revenues, the Indian pharmaceutical industry is ranked 14th in the world in value terms. Being home to more than 10,000 manufacturing units and about 3,000 drug companies, India also ranks third in the world in pharmaceutical production by volume. However, the Indian pharmaceutical industry, although big from any angle you look at it, is heavily dependent on China for the supply of active pharmaceutical ingredients (APIS) and intermediates.
To illustrate, as per the statistics from the Ministry of Chemicals and Fertilisers, in the financial year 2021-22, the import of bulk drugs and drug intermediates from China to India was 23,273 crore (and 2.65 lakh MT in volume), nearly 66 percent of the total imports. During the same period, our total imports stood at 35,249 crore, or 4 lakh MT in volume.
To further India's goal of Aatma-Nirbharta (self-reliance) and reduce the dependency on imports of essential bulk drugs, the Government of India launched a production-linked incentive (PLI) scheme for the pharmaceutical sector in the year 2020.
Originally introduced to boost domestic manufacturing of electronic goods by the Ministry of Electronics and Information Technology in April 2020, the PLI scheme today covers 14 industry verticals including the pharmaceuticals sector.
Stating that the industry response has been good so far, Lokesh Harjani, Founder & CEO, Onspot Solutions, informs that many pharmaceutical companies have applied for registration under the scheme. "More than 300 organizations have applied, and about 50 organizations have already received incentives."
NUTS AND BOLTS OF PLI
This story is from the November 2022 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the November 2022 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
ADDRESSING INDIA'S RURAL CARE GAP
Lakhs of rural Indians lack access to healthcare services. Learn the ways India can improve healthcare accessibility in its rural areas.
iMeUsWe unveils at-home DNA testing services
iMeUsWe and MapMyGenome's at-home DNA testing to offer health and ancestry insights.
CAR T-CELL THERAPY: A PROMISING CANCER TREATMENT ADVANCEMENT
Employing genetically modified immune cells to attack tumors, CAR T-cell therapy offers new hope for cancer patients.
LEADING WITH INNOVATION
\"Every regional market presents a unique set of challenges and opportunities,\" said Ms Zahabiya Khorakiwala, Managing Director, Wockhardt Hospitals Group, during Healthcare Radius Leadership Vidcast.
OVERCOMING INDIA'S AMR CHALLENGE
India faces a growing threat of antimicrobial resistance (AMR). Experts warn of superbugs and ineffective treatments. Is there hope? Read on to find out.
SOCC launches online second opinion for pediatric care
SOCC’s online second opinion consultations for pediatric care aims to bridge the gap in pediatric healthcare services in India.
Clove Dental opens 12 clinics in a single day
Clove Dental marks its 13th anniversary with nationwide expansion. Get full details.
BM Birla Heart Hospital launches cardiac care program
BM Birla Heart Hospital partners with Dozee for Al-powered cardiac care program.
PD Hinduja Hospital goes digital for infection control
Ropes in Ibhar Technologies for infection control, patient safety, and auditing automation.
Maruti Suzuki marks one year of cardiac care in rural Gujarat
Maruti Suzuki celebrates one year of providing advanced cardiac care in rural Gujarat.